Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors
- PMID: 15653346
- DOI: 10.1016/j.bmc.2004.10.036
Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors
Abstract
The structure of sulphostin (1), a novel dipeptidyl peptidase IV (DPP-IV) inhibitor, is consisted of three key functional groups, including a characteristic amino(sulfoamino)phosphinyl group, on a piperidine ring. To examine the relationship between its structure and the inhibitory activity against DPP-IV, various analogues were synthesized and their activities were investigated. These results indicated that all of the functional groups on the piperidine ring were crucial to the DPP-IV inhibitory activity of sulphostin, and that the sulfonic acid group, which constructed the amino(sulfoamino)phosphinyl group, contributed to the stability of the compound. Moreover, those functional groups should be adjoined on the piperidine ring for the inhibitory activity. The size of the nitrogen-containing heterocyclic ring including piperidine appeared to scarcely affect the activity. In the present study, the sulfonic acid-deficient five-membered ring analogue 27a showed the strongest inhibitory activity (IC50=11 nM).
Similar articles
-
First synthesis and determination of the absolute configuration of sulphostin, a novel inhibitor of dipeptidyl peptidase IV.J Nat Prod. 2004 Jun;67(6):999-1004. doi: 10.1021/np030491b. J Nat Prod. 2004. PMID: 15217282
-
Sulphostin, a novel inhibitor of dipeptidyl peptidases IV (DPPIV) that stimulates hematopoiesis in mice.J Antibiot (Tokyo). 2005 Feb;58(2):111-7. doi: 10.1038/ja.2005.14. J Antibiot (Tokyo). 2005. PMID: 15835723
-
Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26.J Med Chem. 1998 Jun 4;41(12):2100-10. doi: 10.1021/jm970640l. J Med Chem. 1998. PMID: 9622551
-
From the bench to the bedside: dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents.Curr Opin Drug Discov Devel. 2008 Jul;11(4):512-32. Curr Opin Drug Discov Devel. 2008. PMID: 18600568 Review.
-
Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition.Clin Sci (Lond). 2009 Sep 28;118(1):31-41. doi: 10.1042/CS20090047. Clin Sci (Lond). 2009. PMID: 19780719 Review.
Cited by
-
Screening for Potential Novel Probiotics With Dipeptidyl Peptidase IV-Inhibiting Activity for Type 2 Diabetes Attenuation in vitro and in vivo.Front Microbiol. 2020 Jan 10;10:2855. doi: 10.3389/fmicb.2019.02855. eCollection 2019. Front Microbiol. 2020. PMID: 31998245 Free PMC article.
-
Sulphostin-inspired N-phosphonopiperidones as selective covalent DPP8 and DPP9 inhibitors.Nat Commun. 2025 Apr 3;16(1):3208. doi: 10.1038/s41467-025-58493-z. Nat Commun. 2025. PMID: 40180908 Free PMC article.
-
Microbial dipeptidyl peptidases of the S9B family as host-microbe isozymes.Sci Adv. 2025 Apr 4;11(14):eads5721. doi: 10.1126/sciadv.ads5721. Epub 2025 Apr 2. Sci Adv. 2025. PMID: 40173242 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources